销售毛利 更改
AstraZeneca USD 12.86B 251M 2026-06
Bayer EUR 8.17B 1.24B 2026-03
Essilor EUR 9.41B 1.12B 2026-06
Fresenius EUR 1.53B 20M 2026-03
Fresenius Medical Care EUR 1.18B 210M 2026-03
GlaxoSmithKline GBP 6.51B 757M 2026-06
GRIFOLS EUR 704M 84M 2026-06
Lonza CHF 1.29B 248M 2025-06
Merck EUR 3.07B 104M 2026-03
Novartis USD 11.24B 1.18B 2026-06
Philips EUR 2.15B 384M 2026-06
Roche Holding CHF 22.69B 600M 2026-06
Sanofi EUR 8.71B 602M 2026-06
Smith & Nephew USD 2.09B 117M 2025-12
Sonova Holding CHF 1.28B 205.2M 2025-12
UCB EUR 3.19B 621M 2025-12